Your browser doesn't support javascript.
loading
Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma.
Li, Aidan C; Zhao, Jing; Zhao, Chao; Ma, Zhongliang; Hartage, Ramon; Zhang, Yunxiang; Li, Xiaoxian; Parwani, Anil V.
Afiliación
  • Li AC; Dublin Jerome High School, Dublin, OH, USA.
  • Zhao J; Department of Pathology, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Zhao C; Center for Biostatistics, Emory University, Atlanta, GA, USA.
  • Ma Z; Department of Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Hartage R; Department of Pathology, The Ohio State University, Columbus, OH, USA.
  • Zhang Y; Department of Pathology, Weifang People's Hospital, Weifang, China.
  • Li X; Department of Pathology, Emory University, Atlanta, GA, USA. xli40@emory.edu.
  • Parwani AV; Department of Pathology, The Ohio State University, Columbus, OH, USA. Anil.Parwani@osumc.edu.
Breast Cancer Res Treat ; 180(2): 321-329, 2020 Apr.
Article en En | MEDLINE | ID: mdl-32002765

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Procesamiento de Imagen Asistido por Computador / Neoplasias de la Mama / Inmunohistoquímica / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Receptor ErbB-2 / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Procesamiento de Imagen Asistido por Computador / Neoplasias de la Mama / Inmunohistoquímica / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Receptor ErbB-2 / Terapia Neoadyuvante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Año: 2020 Tipo del documento: Article